{"id":1084,"date":"2026-07-06T06:02:08","date_gmt":"2026-07-06T06:02:08","guid":{"rendered":"https:\/\/isbm-blow-molding.com\/?p=1084"},"modified":"2026-07-06T06:02:08","modified_gmt":"2026-07-06T06:02:08","slug":"crc-pharmaceutical-injection-blow-molding","status":"publish","type":"post","link":"https:\/\/isbm-blow-molding.com\/fr\/crc-pharmaceutical-injection-blow-molding\/","title":{"rendered":"Guide des contenants \u00e0 l'\u00e9preuve des enfants de CRC Pharmaceutical IBM\u00a0:"},"content":{"rendered":"<div style=\"margin: 0; padding: 0; font-family: 'Helvetica Neue',Helvetica,Arial,sans-serif; color: #1a2332; line-height: 1.78; background: #f0f3f7; overflow-x: hidden;\">\n<p><!-- \u2550\u2550 HERO \u2550\u2550 --><\/p>\n<header style=\"position: relative; min-height: min(600px,88vh); display: flex; align-items: flex-end; width: 100%; background: #0c0e1a; background-image: linear-gradient(155deg,rgba(8,10,22,0.97) 0%,rgba(16,20,48,0.93) 52%,rgba(30,48,110,0.60) 100%),url('https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Pharmaceutical-Bottles.webp'); background-size: cover; background-position: center 35%;\">\n<div style=\"position: absolute; top: 0; left: 0; right: 0; height: 5px; background: linear-gradient(90deg,#d97706,#f59e0b,#d97706);\"><\/div>\n<div style=\"position: absolute; bottom: -1px; left: 0; right: 0; height: 56px; background: #f0f3f7; clip-path: polygon(0 100%,100% 100%,100% 0);\"><\/div>\n<div style=\"position: relative; z-index: 2; width: 100%; padding: clamp(48px,7vw,96px) clamp(20px,5vw,60px) clamp(52px,6vw,84px); box-sizing: border-box;\">\n<div style=\"display: inline-flex; align-items: center; gap: 8px; margin-bottom: 20px;\">\n<div style=\"width: 28px; height: 3px; background: #d97706;\"><\/div>\n<p><span style=\"font-size: 10px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #f59e0b;\">CRC PHARMACEUTICAL IBM \u00b7 KS M ISO 8317 \u00b7 KFDA COR\u00c9ENNE \u00b7 EVER-POWER COR\u00c9E<\/span><\/p>\n<div style=\"width: 28px; height: 3px; background: #d97706;\"><\/div>\n<\/div>\n<h1 style=\"font-size: clamp(26px,4.6vw,46px); font-weight: 900; color: #fff; line-height: 1.1; margin: 0 0 20px; letter-spacing: -0.8px; max-width: 720px;\">CRC Pharmaceutical IBM\u00a0:<br \/>\n<span style=\"color: #f59e0b;\">\u00e0 l'\u00e9preuve des enfants<\/span> Guide des conteneurs<\/h1>\n<p style=\"font-size: clamp(14px,1.9vw,17px); color: #94a3b8; line-height: 1.7; margin: 0 0 30px; max-width: 600px;\">Korean child-resistant closure (CRC) pharmaceutical containers are the application where IBM&#8217;s \u00b10.05 mm neck OD precision is not merely an advantage over EBM \u2014 it is the prerequisite for Korean KS M ISO 8317 compliance. This guide covers CRC engagement mechanism physics, IBM neck geometry specifications, Korean ISO 8317 test requirements, HDPE grade selection and ZQ series machine selection for Korean CRC pharmaceutical container production.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 6px;\"><span style=\"background: rgba(217,119,6,0.15); border: 1px solid rgba(217,119,6,0.45); color: #fbbf24; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">Conformit\u00e9 KS M ISO 8317<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.15); color: #94a3b8; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">Diam\u00e8tre ext\u00e9rieur de la bille CRC \u00b10,05 mm<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.06); border: 1px solid rgba(255,255,255,0.15); color: #94a3b8; font-size: 11px; font-weight: bold; padding: 4px 12px; border-radius: 2px; letter-spacing: 1px; text-transform: uppercase;\">M\u00e9canisme de pouss\u00e9e et de rotation<\/span><\/div>\n<p style=\"font-size: 11px; color: #475569; margin: 22px 0 0; letter-spacing: 1px;\">COR\u00c9E EVER-POWER \u00b7 ANSAN-SI, GYEONGGI-DO \u00b7 JUILLET 2026<\/p>\n<\/div>\n<\/header>\n<p>&nbsp;<\/p>\n<p><!-- SPEC PANEL --><\/p>\n<div style=\"background: #0f1e35; border: 1px solid #1e3a5f; border-left: 4px solid #d97706; border-radius: 4px; padding: 24px 28px; margin: 52px 0 0;\">\n<div style=\"display: flex; align-items: center; gap: 10px; margin-bottom: 18px;\">\n<div style=\"width: 16px; height: 16px; border: 2px solid #d97706; border-radius: 50%; display: flex; align-items: center; justify-content: center; flex-shrink: 0;\">\n<div style=\"width: 6px; height: 6px; background: #d97706; border-radius: 50%;\"><\/div>\n<\/div>\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">R\u00c9F\u00c9RENCE SYST\u00c8ME \u00b7 PARAM\u00c8TRES IBM DE CRC PHARMACEUTICAL COR\u00c9EN<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,170px),1fr)); gap: 1px; background: #1e3a5f;\">\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">TOL\u00c9RANCE DU DIAM\u00c8TRE EXT\u00c9RIEUR DES PERLES CRC<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">Moul\u00e9 par injection IBM \u2014 Fen\u00eatre ISO 8317 cor\u00e9enne \u00b10,06 mm<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">KS M ISO 8317 ADULT<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u2265 85%<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">Taux d'ouverture en moins de 5 minutes \u2014 200 sujets adultes test\u00e9s<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">KS M ISO 8317 ENFANT<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u2264 20%<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">Taux d'ouverture en moins de 10 minutes \u2014 200 sujets enfants (42\u201351 mois)<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #475569; margin: 0 0 6px;\">RIGIDIT\u00c9 DES PERLES EN PEHD<\/p>\n<p style=\"font-size: 24px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">MI 0,5\u20130,8<\/p>\n<p style=\"font-size: 12px; color: #64748b; margin: 0;\">g\/10 min \u00b7 densit\u00e9 0,955\u20130,965 \u2014 la bille r\u00e9siste \u00e0 la d\u00e9formation par compression CRC<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- TOC --><\/p>\n<nav style=\"margin: 28px 0 0; background: #fff; border: 1px solid #cbd5e0; border-radius: 4px; padding: 22px 26px; position: relative; overflow: hidden;\">\n<div style=\"position: absolute; inset: 0; background-image: linear-gradient(rgba(30,58,95,0.03) 1px,transparent 1px),linear-gradient(90deg,rgba(30,58,95,0.03) 1px,transparent 1px); background-size: 24px 24px; pointer-events: none;\"><\/div>\n<div style=\"position: relative;\">\n<div style=\"display: flex; align-items: center; gap: 8px; margin-bottom: 14px;\">\n<div style=\"width: 3px; height: 14px; background: #d97706; border-radius: 2px;\"><\/div>\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 2.5px; text-transform: uppercase; color: #1e3a5f; margin: 0;\">INDEX DES DOCUMENTS<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,270px),1fr)); gap: 2px 24px;\"><a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s1\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">01<\/span>March\u00e9 pharmaceutique cor\u00e9en du cancer colorectal et IBM<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s2\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">02<\/span>M\u00e9canisme d'engagement CRC et pr\u00e9cision du cou IBM<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s3\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">03<\/span>Exigences de test cor\u00e9ennes KS M ISO 8317<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s4\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">04<\/span>Qualit\u00e9 et g\u00e9om\u00e9trie des perles de PEHD pour CRC IBM<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s5\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">05<\/span>Param\u00e8tres de traitement IBM pour les conteneurs CRC<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s6\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">06<\/span>Gamme de formats CRC et s\u00e9lection de finitions de manche<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s7\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">07<\/span>Format combin\u00e9 CRC + Scellage par induction<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline; border-bottom: 1px solid #f1f5f9;\" href=\"#s8\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">08<\/span>S\u00e9lection de la s\u00e9rie ZQ pour IBM CRC cor\u00e9en<\/a><br \/>\n<a style=\"color: #1e3a5f; text-decoration: none; font-size: 13.5px; padding: 4px 0; display: flex; align-items: baseline;\" href=\"#faq\"><span style=\"color: #d97706; font-size: 10px; font-weight: 800; margin-right: 8px; flex-shrink: 0;\">FAQ<\/span>Questions d'ing\u00e9nierie<\/a><\/div>\n<\/div>\n<\/nav>\n<p><!-- \u2550\u2550 S1 \u2550\u2550 --><\/p>\n<div style=\"padding: 0px 2%;\">\n<section id=\"s1\" style=\"margin: 64px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 01<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">March\u00e9 cor\u00e9en des conteneurs pharmaceutiques CRC et IBM<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">En Cor\u00e9e, les emballages pharmaceutiques \u00e0 fermeture s\u00e9curis\u00e9e enfant (FSE) sont obligatoires pour une liste sp\u00e9cifique et croissante de cat\u00e9gories de produits pharmaceutiques. Le Service cor\u00e9en d'\u00e9valuation et de contr\u00f4le de l'assurance maladie (HIRA) impose un emballage FSE pour tous les m\u00e9dicaments sur ordonnance cor\u00e9ens contenant des substances actives toxiques \u00e0 des doses sup\u00e9rieures aux seuils sp\u00e9cifi\u00e9s, pour toutes les formulations liquides p\u00e9diatriques sur ordonnance distribu\u00e9es aux familles avec des enfants de moins de six ans, et pour tous les analg\u00e9siques en vente libre, sous forme de comprim\u00e9s ou de solution buvable, conditionn\u00e9s \u00e0 des doses sup\u00e9rieures \u00e0 unitaire. Depuis 2020, le minist\u00e8re cor\u00e9en de la S\u00e9curit\u00e9 alimentaire et pharmaceutique (MFDS\/KFDA) renforce progressivement l'application des exigences relatives aux FSE, \u00e9largissant ainsi la liste des produits pharmaceutiques cor\u00e9ens n\u00e9cessitant un emballage primaire FSE au-del\u00e0 de la liste initiale, plus restreinte.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><a href=\"https:\/\/isbm-blow-molding.com\/fr\/product-category\/4-station-isbm-machine\/\">IBM<\/a> is the exclusive blow molding process for Korean pharmaceutical CRC containers because the push-and-turn CRC mechanism&#8217;s engagement tolerance window (\u00b10.06 mm on neck engagement bead OD) falls within IBM&#8217;s native \u00b10.05 mm neck precision but exceeds EBM&#8217;s \u00b10.15\u20130.25 mm neck tolerance by a factor of 3\u20135\u00d7. No secondary neck processing applied to EBM containers can reliably achieve \u00b10.06 mm CRC engagement bead OD across 2\u20134 cavities at the production speed required for Korean pharmaceutical filling lines \u2014 the neck processing reaming operation&#8217;s own dimensional variation (\u00b10.08\u20130.12 mm reaming tolerance) exceeds the CRC engagement window. IBM eliminates this process chain by producing the engagement bead at \u00b10.05 mm in the injection mould neck insert as a primary process capability, not as the result of secondary finishing.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Le guide plus g\u00e9n\u00e9ral sur les emballages pharmaceutiques (IBM) couvre de mani\u00e8re exhaustive les formats de contenants primaires pharmaceutiques cor\u00e9ens. Ce guide se concentre sp\u00e9cifiquement sur les emballages CRC (emballages \u00e0 col rond)\u00a0: la physique du m\u00e9canisme d\u2019embo\u00eetement, les sp\u00e9cifications g\u00e9om\u00e9triques du col, la conformit\u00e9 \u00e0 la norme cor\u00e9enne ISO\u00a08317, le choix de la qualit\u00e9 du PEHD et les aspects \u00e9conomiques de production propres \u00e0 ce format.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S2 \u2550\u2550 --><\/p>\n<section id=\"s2\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 02<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">M\u00e9canisme d'engagement CRC et pr\u00e9cision du cou IBM<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"IBM CRC Neck Precision \u2014 Core Rod Mechanism Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-Internal-structure.webp\" alt=\"Korea Ever-Power ZQ series IBM machine internal structure showing core rod mechanism that holds CRC engagement bead geometry through injection and blow phase \u2014 producing \u00b10.05mm bead OD across all cavities for Korean KS M ISO 8317 push-and-turn CRC pharmaceutical container production\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">IBM&#8217;s core rod mechanism is the physical basis of CRC neck precision. The core rod passes through the CRC engagement bead zone at Station 1 (injection) and Station 2 (blow), holding the bead geometry exactly as defined by the injection mould neck insert throughout both process phases. Blow air pressure at Station 2 never contacts the bead \u2014 it acts on the preform body only, below the bead zone. This structural decoupling of bead geometry from blow pressure is why IBM achieves \u00b10.05 mm CRC bead OD while EBM, where blow pressure forms the entire container including the neck, cannot achieve \u00b10.06 mm without secondary neck finishing.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Le bouchon CRC \u00e0 verrouillage par pouss\u00e9e et rotation fonctionne gr\u00e2ce \u00e0 un syst\u00e8me d'engagement m\u00e9canique entre une but\u00e9e de retenue circonf\u00e9rentielle sur le col de la bouteille IBM en PEHD et un cliquet d'engagement correspondant situ\u00e9 \u00e0 l'int\u00e9rieur de la jupe du bouchon CRC. La compr\u00e9hension du principe de ce m\u00e9canisme d'engagement est essentielle pour sp\u00e9cifier correctement la g\u00e9om\u00e9trie de l'insert de col IBM.<\/p>\n<p><!-- CRC mechanism diagram panel --><\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; overflow: hidden; margin: 0 0 22px; border-top: 3px solid #d97706;\">\n<div style=\"padding: 14px 20px; border-bottom: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">CRC \u00c0 POUSSER ET TOURNER \u2014 M\u00c9CANIQUES D'ENGAGEMENT ET CHA\u00ceNE DE TOL\u00c9RANCE DE COL IBM<\/p>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 16px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">\u00c9tape 1 \u2014 Appuyez vers le bas<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">The Korean patient or pharmacist presses the CRC cap downward, compressing the cap skirt&#8217;s spring ratchet teeth over the HDPE neck bead. The engagement bead OD determines the interference force: if bead OD is too wide, the required push-down force exceeds Korean elderly patient capability (adult accessibility failure). If bead OD is too narrow, ratchet teeth cannot compress adequately and CRC function is lost.<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">\u00c9tape 2 \u2014 Tourner en appuyant sur<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">Tout en maintenant une pression vers le bas, le bouchon est tourn\u00e9 (g\u00e9n\u00e9ralement de 30 \u00e0 45\u00b0) afin d'aligner les dents du cliquet avec le d\u00e9but du filetage du goulot. La tol\u00e9rance IBM de \u00b10,05 mm sur le diam\u00e8tre ext\u00e9rieur du filetage garantit que le d\u00e9but du filetage s'engage \u00e0 1 ou 2\u00b0 du point d'engagement pr\u00e9vu, \u00e9vitant ainsi tout blocage du filetage qui augmenterait l'effort de rotation au-del\u00e0 des sp\u00e9cifications et entra\u00eenerait un \u00e9chec aux tests d'accessibilit\u00e9 pour adultes.<\/p>\n<\/div>\n<div style=\"padding: 16px 18px;\">\n<p style=\"font-size: 10px; font-weight: bold; color: #f59e0b; margin: 0 0 10px; letter-spacing: 1px; text-transform: uppercase;\">\u00c9tape 3 \u2014 Lib\u00e9rer et v\u00e9rifier<\/p>\n<p style=\"font-size: 13.5px; color: #e2e8f0; margin: 0; line-height: 1.65;\">Cap released \u2014 the spring ratchet re-engages the retention bead, locking the cap in the open position (child cannot re-close) or in the closed thread engagement position (product sealed). IBM neck geometry ensures consistent ratchet engagement depth across all production cavities: bead height \u00b10.05 mm, bead profile radius \u00b10.03 mm \u2014 both produced by the injection mould neck insert and verified in Korea Ever-Power&#8217;s pre-delivery production trial.<\/p>\n<\/div>\n<\/div>\n<div style=\"padding: 12px 20px; border-top: 1px solid #1e3a5f; background: #0a1628; display: grid; grid-template-columns: repeat(auto-fit,minmax(150px,1fr)); gap: 12px;\">\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">PERLE OD IBM<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">\u00b10,05 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">FEN\u00caTRE ISO 8317<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">\u00b10,06 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">TOL\u00c9RANCE EBM<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #f87171; margin: 0;\">\u00b10,15\u20130,25 mm<\/p>\n<\/div>\n<div style=\"text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 3px; font-weight: bold;\">MARGE DE PROCESSUS<\/p>\n<p style=\"font-size: 15px; font-weight: 900; color: #34d399; margin: 0;\">+0,01 mm IBM<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">IBM produces the CRC engagement bead entirely within the injection mould neck insert \u2014 a precision-machined steel component that defines the bead OD, bead height, bead profile radius and bead axial position simultaneously in a single injection stroke. The neck insert is manufactured from S136 stainless steel (HRC 50\u201352) with CNC turning tolerance of \u00b10.01 mm on all bead geometry dimensions, producing a finished IBM container bead OD at \u00b10.05 mm across all production cavities after accounting for HDPE shrinkage compensation (0.8\u20131.2% applied to the mould bead OD dimension during neck insert CNC machining). Korea Ever-Power&#8217;s pharmaceutical IBM neck insert design uses finite element simulation of HDPE shrinkage at the bead zone \u2014 the bead&#8217;s locally higher wall section shrinks differently from the adjacent cylindrical neck \u2014 to calculate the correct mould bead OD that produces the specified container bead OD at the HDPE IBM processing temperature and cooling rate.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S3 \u2550\u2550 --><\/p>\n<section id=\"s3\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 03<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Tests d'efficacit\u00e9 de la s\u00e9curit\u00e9 enfant selon la norme cor\u00e9enne KS M ISO 8317<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"IBM CRC Container Production \u2014 Korea Ever-Power ZQ Series\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/IBM-operating-principle.webp\" alt=\"IBM 3-station CRC pharmaceutical container production \u2014 injection moulding CRC engagement bead at Station 1, blow moulding container body at Station 2, stripping at Station 3 \u2014 Korea Ever-Power ZQ80 12-cavity 100ml CRC pharmaceutical IBM producing containers for Korean KS M ISO 8317 child-resistant closure qualification testing\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">Production IBM en 3 stations de conteneurs pharmaceutiques CRC\u00a0: le bourrelet d\u2019engagement est moul\u00e9 par injection \u00e0 la station 1 et maintenu dimensionnellement stable par la tige centrale pendant la phase de soufflage \u00e0 la station 2. \u00c0 la station 3 de d\u00e9moulage, le conteneur CRC fini est lib\u00e9r\u00e9 avec un diam\u00e8tre ext\u00e9rieur du bourrelet conforme \u00e0 la sp\u00e9cification de \u00b10,05 mm, pr\u00eat pour la v\u00e9rification dimensionnelle de pr\u00e9qualification cor\u00e9enne KS M ISO 8317 avant les tests formels sur panel humain ISO 8317.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">La norme cor\u00e9enne KS M ISO 8317 est la norme nationale cor\u00e9enne relative aux emballages \u00e0 l'\u00e9preuve des enfants, harmonis\u00e9e avec la norme ISO 8317:2015. Elle sp\u00e9cifie un test aupr\u00e8s d'un panel humain compos\u00e9 de 200 adultes et 200 enfants afin de v\u00e9rifier que le syst\u00e8me de fermeture du contenant r\u00e9pond simultan\u00e9ment aux exigences de r\u00e9sistance \u00e0 l'ouverture par les enfants (faible taux d'ouverture) et d'accessibilit\u00e9 par les adultes (taux d'ouverture \u00e9lev\u00e9). Ce test doit \u00eatre r\u00e9alis\u00e9 avec des contenants de production remplis \u2013 et non avec des contenants vides ou des \u00e9chantillons de laboratoire \u2013 car le poids du contenu, la viscosit\u00e9 du liquide et le couple de serrage du syst\u00e8me de fermeture influent sur les performances du syst\u00e8me de fermeture lors du test.<\/p>\n<p><!-- ISO 8317 test requirements --><\/p>\n<div style=\"display: flex; flex-direction: column; gap: 0; border: 1px solid #1e3a5f; border-radius: 6px; overflow: hidden; margin: 0 0 22px;\">\n<div style=\"background: #0f1e35; display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #d97706; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">PARAM\u00c8TRE DE TEST<\/p>\n<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #f59e0b; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">PANEL ENFANTS (42\u201351 mois)<\/p>\n<\/div>\n<div style=\"padding: 12px 18px;\">\n<p style=\"font-size: 9px; font-weight: 800; color: #f59e0b; margin: 0; letter-spacing: 1.5px; text-transform: uppercase;\">PANEL ADULTE (50\u201370 ans)<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">Taille du panneau<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\">200 enfants<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\">200 adultes (\u00e2g\u00e9s de 50 \u00e0 70 ans)<\/div>\n<\/div>\n<div style=\"background: #f8fafc; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">limite de temps<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\">10 minutes<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\">5 minutes (test de fermeture inclus)<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">Crit\u00e8re de r\u00e9ussite<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 14px; text-align: center;\"><strong style=\"color: #059669;\">\u2264 20%<\/strong> enfants ouverts<\/div>\n<div style=\"padding: 12px 18px; font-size: 14px; text-align: center;\"><strong style=\"color: #059669;\">\u2265 85%<\/strong> adultes ouverts<\/div>\n<\/div>\n<div style=\"background: #f8fafc; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-weight: 600; font-size: 14px;\">Impact OD du cou IBM<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #e2e8f0; font-size: 13.5px; color: #374151;\">Diam\u00e8tre ext\u00e9rieur du cordon \u00e9lev\u00e9 \u2192 plus d'interf\u00e9rences \u2192 ouverture plus difficile \u2192 s\u00e9curit\u00e9 enfant \u2713 mais inaccessible aux adultes \u2717<\/div>\n<div style=\"padding: 12px 18px; font-size: 13.5px; color: #374151;\">Diam\u00e8tre ext\u00e9rieur des perles faible \u2192 moins d'interf\u00e9rences \u2192 acc\u00e8s facile pour les adultes \u2713 mais r\u00e9sistance enfant insuffisante \u2717<\/div>\n<\/div>\n<div style=\"background: #fffbeb; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #fde68a;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #fde68a; font-weight: bold; font-size: 14px; color: #92400e;\">Avantage IBM<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #fde68a; font-size: 13.5px; color: #92400e; font-weight: 600;\">Le diam\u00e8tre ext\u00e9rieur des perles IBM de \u00b10,05 mm maintient tous les contenants de production dans la plage de tol\u00e9rance de \u00b10,06 mm qui satisfait simultan\u00e9ment aux DEUX crit\u00e8res \u2014 sans jamais d\u00e9river vers une d\u00e9faillance de la s\u00e9curit\u00e9 enfant (trop facile) ou une d\u00e9faillance de l'accessibilit\u00e9 adulte (trop difficile).<\/div>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Le dossier technique des contenants pharmaceutiques aupr\u00e8s de la KFDA cor\u00e9enne doit inclure le certificat de test cor\u00e9en KS M ISO 8317 pour chaque contenant CRC. Ce document est d\u00e9livr\u00e9 par un laboratoire d'essais cor\u00e9en accr\u00e9dit\u00e9 KS ayant r\u00e9alis\u00e9 le test sur un panel humain \u00e0 l'aide de contenants de production issus de la machine IBM et du moule identifi\u00e9s dans le dossier technique. Korea Ever-Power fournit des \u00e9chantillons de contenants CRC IBM provenant de l'essai de production avant livraison, sp\u00e9cifiquement pour ce test. Cela permet \u00e0 la marque pharmaceutique cor\u00e9enne de soumettre simultan\u00e9ment les \u00e9chantillons de test ISO 8317 et le dossier technique, optimisant ainsi la probabilit\u00e9 que le r\u00e9sultat de r\u00e9ussite du test ISO 8317 et le dossier technique complet soient disponibles en m\u00eame temps pour l'examen de qualification BPF de la KFDA cor\u00e9enne.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S4 \u2550\u2550 --><\/p>\n<section id=\"s4\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 04<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Qualit\u00e9 du PEHD et g\u00e9om\u00e9trie des bourrelets pour les conteneurs CRC IBM<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Korean CRC pharmaceutical IBM containers require a specific HDPE grade characteristic that non-CRC pharmaceutical IBM does not: the bead zone must resist plastic deformation under CRC push-down force. When the CRC cap is pushed down, it applies approximately 20\u201350 N downward force on the HDPE engagement bead \u2014 the bead must spring back to its original OD after the push-down force is released to maintain consistent child resistance at the next opening attempt. HDPE with insufficient stiffness (too high MI or too low density) permanently deforms under repeated push-down forces, effectively widening the bead OD over time and reducing child resistance below Korean ISO 8317 requirements within the product&#8217;s shelf life.<\/p>\n<p><!-- bead geometry specification --><\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; padding: 22px 26px; margin: 0 0 22px; border-top: 3px solid #d97706;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 16px;\">G\u00c9OM\u00c9TRIE DES PERLES D'ENGAGEMENT CRC \u00b7 SP\u00c9CIFICATIONS DE L'INSERT DE COL POUR MOULEMENT D'INJECTION IBM<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,180px),1fr)); gap: 1px; background: #1e3a5f;\">\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Diam\u00e8tre ext\u00e9rieur du bourrelet<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">Valeur nominale \u00b10,01 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Cavit\u00e9 du moule (avec correction du retrait du PEHD appliqu\u00e9e)<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Hauteur des perles<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">0,8\u20131,5 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Cylindre de diam\u00e8tre ext\u00e9rieur nominal sup\u00e9rieur \u00e0 celui du col \u2014 fournisseur sp\u00e9cifique de bouchons CRC cor\u00e9ens<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Rayon du profil de la perle<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">R 0,3\u20130,6 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">Amor\u00e7age en douceur pour l'engagement des dents du cliquet CRC \u2014 le rayon aigu augmente le bruit et la force d'engagement<\/p>\n<\/div>\n<div style=\"background: #0f1e35; padding: 14px 16px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; margin: 0 0 6px; font-weight: bold; letter-spacing: 1px;\">Position axiale de la perle<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #f59e0b; margin: 0 0 4px;\">\u00b10,20 mm<\/p>\n<p style=\"font-size: 11px; color: #64748b; margin: 0;\">\u00c0 partir de la surface d'\u00e9tanch\u00e9it\u00e9 du col \u2014 d\u00e9termine l'emplacement axial en position ferm\u00e9e du capuchon CRC<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><!-- HDPE grade specs --><\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,280px),1fr)); gap: 14px; margin: 0 0 22px;\">\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-top: 3px solid #d97706; border-radius: 4px; padding: 18px 20px;\">\n<p style=\"font-size: 10px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #d97706; margin: 0 0 12px;\">CRC IBM cor\u00e9en \u2014 Qualit\u00e9 de PEHD recommand\u00e9e<\/p>\n<div style=\"display: grid; grid-template-columns: 1fr 1fr; gap: 8px; margin-bottom: 14px;\">\n<div style=\"background: #f8fafc; padding: 10px 12px; border-radius: 3px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; font-weight: bold; margin: 0 0 3px; letter-spacing: 1px;\">MI (190\u00b0C\/2,16kg)<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #d97706; margin: 0;\">0,5\u20130,8<\/p>\n<\/div>\n<div style=\"background: #f8fafc; padding: 10px 12px; border-radius: 3px; text-align: center;\">\n<p style=\"font-size: 10px; color: #475569; font-weight: bold; margin: 0 0 3px; letter-spacing: 1px;\">Densit\u00e9 (g\/cm\u00b3)<\/p>\n<p style=\"font-size: 18px; font-weight: 900; color: #d97706; margin: 0;\">0,955\u20130,965<\/p>\n<\/div>\n<\/div>\n<p style=\"font-size: 14px; color: #374151; margin: 0; line-height: 1.65;\">Une densit\u00e9 plus \u00e9lev\u00e9e (0,955\u20130,965) et un indice de malachite (IM) plus faible (0,5\u20130,8) que les emballages pharmaceutiques standard en PEHD IBM permettent d'obtenir un bourrelet plus rigide, r\u00e9sistant \u00e0 la d\u00e9formation par fluage lors de cycles r\u00e9p\u00e9t\u00e9s d'ouverture par pression sur les emballages de s\u00e9curit\u00e9 enfant (ESE) pendant toute la dur\u00e9e de conservation pharmaceutique cor\u00e9enne de 24 mois. Une densit\u00e9 \u2265 0,958 est recommand\u00e9e pour les ESE cor\u00e9ens, qui doivent maintenir leur r\u00e9sistance \u00e0 l'ouverture par pression apr\u00e8s 30 cycles (test de cyclage des ESE conforme \u00e0 la norme HIRA cor\u00e9enne).<\/p>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-top: 3px solid #1e3a5f; border-radius: 4px; padding: 18px 20px;\">\n<p style=\"font-size: 10px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #1e3a5f; margin: 0 0 12px;\">Facteurs de risque de d\u00e9formation des perles<\/p>\n<ul style=\"margin: 0; padding-left: 0; list-style: none; display: flex; flex-direction: column; gap: 8px;\">\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>PEHD MI sup\u00e9rieur \u00e0 1,0\u00a0:<\/strong> Poids mol\u00e9culaire insuffisant pour la r\u00e9sistance au fluage des billes \u2014 \u00e0 \u00e9viter pour le m\u00e9dicament IBM contre le cancer colorectal cor\u00e9en<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>Densit\u00e9 inf\u00e9rieure \u00e0 0,952\u00a0:<\/strong> Une cristallinit\u00e9 plus faible r\u00e9duit la rigidit\u00e9 des billes\u00a0; le risque de d\u00e9faillance lors du test de cyclage ISO 8317 augmente apr\u00e8s plus de 15 cycles de compression.<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>Temp\u00e9rature du canon sup\u00e9rieure \u00e0 222 \u00b0C au niveau de la buse\u00a0:<\/strong> La d\u00e9gradation thermique r\u00e9duit la masse mol\u00e9culaire du PEHD au niveau du cordon de soudure, ce qui diminue la rigidit\u00e9 et la r\u00e9sistance au fluage par rapport aux propri\u00e9t\u00e9s nominales.<\/li>\n<li style=\"font-size: 14px; color: #374151; display: flex; align-items: baseline; gap: 8px;\"><span style=\"color: #d97706; font-weight: bold; flex-shrink: 0;\">\u25b8<\/span><strong>Pression de maintien insuffisante au niveau du canal de la bille\u00a0:<\/strong> La zone de cordon sous-compact\u00e9e pr\u00e9sente des micro-vides qui r\u00e9duisent la densit\u00e9 locale\u00a0; mesurer la duret\u00e9 de la zone de cordon (Shore D) par rapport aux sp\u00e9cifications comme indicateur de contr\u00f4le du processus<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- \u2550\u2550 S5 \u2550\u2550 --><\/p>\n<section id=\"s5\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 05<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Param\u00e8tres de traitement IBM pour les conteneurs CRC<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Le traitement IBM pharmaceutique CRC sur les machines cor\u00e9ennes Ever-Power s\u00e9rie ZQ n\u00e9cessite deux ajustements de param\u00e8tres par rapport au traitement IBM pharmaceutique standard non-CRC\u00a0: une pression de maintien plus \u00e9lev\u00e9e (pour un remplissage complet du cordon et une stabilit\u00e9 dimensionnelle optimale) et un refroidissement plus efficace de la zone de col (pour minimiser la d\u00e9rive du diam\u00e8tre ext\u00e9rieur du cordon apr\u00e8s \u00e9jection due \u00e0 la chaleur r\u00e9siduelle). Tous les autres param\u00e8tres sont conformes aux recommandations standard pour le traitement IBM en PEHD pharmaceutique.<\/p>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 540px;\">\n<thead>\n<tr style=\"background: #0f1e35;\">\n<th style=\"color: #f59e0b; padding: 11px 12px; text-align: left; font-weight: bold; border-right: 1px solid #1e3a5f;\">PARAM\u00c8TRE<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">STANDARD PHARMA IBM<\/th>\n<th style=\"color: #f59e0b; padding: 11px 10px; text-align: center; font-weight: bold;\">CRC PHARMA IBM \u2014 AJUSTEMENT<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">Maintenir la pression<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">50\u201365% du pic<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">65\u201375% de pic \u2014 zone de billes \u00e0 remplissage complet<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">Temps d'attente<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">0,4\u20130,8 s<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">0,6\u20131,0 s \u2014 prolong\u00e9 pour assurer l'\u00e9tanch\u00e9it\u00e9 du joint \u00e0 bille<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">temp\u00e9rature du moule dans la zone du cou<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">14\u201318\u00b0C<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">12\u201316 \u00b0C \u2014 refroidissement plus serr\u00e9 au niveau du cordon pour fixer plus rapidement le diam\u00e8tre ext\u00e9rieur<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: 600;\">zone de dosage<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">200\u2013215\u00b0C<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; text-align: center;\">200\u2013215\u00b0C (inchang\u00e9)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #e2e8f0; font-weight: 600;\">Fr\u00e9quence de mesure du diam\u00e8tre ext\u00e9rieur des perles<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center;\">30 par cavit\u00e9 et par lot<\/td>\n<td style=\"padding: 9px 10px; text-align: center; font-weight: bold; color: #d97706;\">30 par cavit\u00e9 + contr\u00f4le en milieu de lot toutes les 2 heures<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e2e8f0; border-left: 4px solid #dc2626; padding: 14px 20px; border-radius: 0 4px 4px 0;\">\n<p style=\"font-size: 13.5px; color: #374151; margin: 0; line-height: 1.7;\"><strong style=\"color: #dc2626;\">\u26a0 D\u00c9RIVATION DU DIAM\u00c8TRE EXT\u00c9RIEUR DU PERLE APR\u00c8S \u00c9JECTION\u00a0:<\/strong> Le diam\u00e8tre ext\u00e9rieur (DE) du cordon d'engagement CRC, mesur\u00e9 imm\u00e9diatement apr\u00e8s le d\u00e9moulage (station 3), est g\u00e9n\u00e9ralement sup\u00e9rieur de 0,02 \u00e0 0,04 mm \u00e0 celui mesur\u00e9 30 minutes apr\u00e8s l'\u00e9jection. Ceci s'explique par la chaleur r\u00e9siduelle dans la zone du cordon lors de l'\u00e9jection, qui favorise la poursuite du retrait induit par la cristallisation du PEHD, r\u00e9duisant ainsi l\u00e9g\u00e8rement le DE. Pour les mesures de qualification KFDA cor\u00e9ennes, le DE du cordon doit \u00eatre mesur\u00e9 apr\u00e8s stabilisation des contenants \u00e0 23 \u00b0C \u00b1 2 \u00b0C pendant au moins 30 minutes apr\u00e8s l'\u00e9jection. Un \u00e9chantillonnage du DE du cordon imm\u00e9diatement \u00e0 la sortie du convoyeur de la machine n'est pas une mesure de qualification valide pour les besoins de la KFDA cor\u00e9enne, car il surestime syst\u00e9matiquement le DE de production stabilis\u00e9.<\/p>\n<\/div>\n<\/section>\n<p><!-- \u2550\u2550 S6 \u2550\u2550 --><\/p>\n<section id=\"s6\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 06<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Gamme de formats de contenants CRC et s\u00e9lection de finitions de col<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"Korean CRC Pharmaceutical IBM Container Format Range \u2014 Korea Ever-Power\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/Typles-0f-Bottle-1.webp\" alt=\"Korean CRC pharmaceutical IBM container format range \u2014 60ml push-and-turn CRC paediatric syrup 28\/400 neck, 100ml push-and-turn CRC medicine bottle 33\/400 neck, 150ml CRC prescription liquid 33\/400 \u2014 Korea Ever-Power ZQ80 CRC pharmaceutical IBM containers for Korean KFDA KS M ISO 8317 qualification\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">Korean CRC pharmaceutical IBM container format range \u2014 from 60 ml paediatric CRC syrup (28\/400 push-and-turn, high-priority Korean HIRA mandate) through 100 ml prescription medicine CRC (33\/400, standard adult Korean CRC format) to 150 ml Korean multi-dose prescription liquid with CRC. All formats are produced by Korea Ever-Power ZQ series IBM machines with engagement bead OD verified in the pre-delivery production trial against the Korean CRC cap supplier&#8217;s engagement drawing.<\/figcaption><\/figure>\n<div style=\"overflow-x: auto; margin: 0 0 22px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 600px;\">\n<thead>\n<tr style=\"background: #0f1e35;\">\n<th style=\"color: #f59e0b; padding: 11px 12px; text-align: left; font-weight: bold; border-right: 1px solid #1e3a5f;\">VOLUME<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">FINITION DU COL<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">TYPE CRC<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: center; font-weight: bold; border-right: 1px solid #1e3a5f;\">CAVIT\u00c9S ZQ80<\/th>\n<th style=\"color: #e2e8f0; padding: 11px 10px; text-align: left; font-weight: bold;\">APPLICATION COR\u00c9ENNE<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">30 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">24\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">Pousser et tourner<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">16\u201318<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Analg\u00e9sique p\u00e9diatrique cor\u00e9en, antibiotique liquide cor\u00e9en en dose unitaire<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold; color: #d97706;\">60 ml \u2605<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">28\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">Pousser et tourner<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">14<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; font-weight: 600; color: #0f1e35;\">Sirop p\u00e9diatrique cor\u00e9en CRC (format CRC cor\u00e9en le plus courant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">100 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">Pousser et tourner<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">10\u201312<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Antibiotique oral sur ordonnance cor\u00e9en, analg\u00e9sique liquide pour adultes cor\u00e9ens<\/td>\n<\/tr>\n<tr style=\"background: #f8fafc;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; font-weight: bold;\">150 ml<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center;\">Pousser et tourner<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">8<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #e2e8f0;\">Solution buvable multidose sur ordonnance cor\u00e9enne, suspension antiacide cor\u00e9enne CRC<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #e2e8f0; font-weight: bold;\">100\u2013150 ml<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center; font-weight: 600;\">33\/400 GPI<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center;\">Presser et tourner<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #e2e8f0; text-align: center; font-weight: bold; color: #d97706;\">8\u201310<\/td>\n<td style=\"padding: 9px 10px;\">CCR chez un patient cor\u00e9en \u00e2g\u00e9 et arthritique (force de pouss\u00e9e inf\u00e9rieure \u00e0 celle de la pouss\u00e9e et de la rotation)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 12px; color: #64748b; margin: 4px 0 0;\">\u2605 Le flacon CRC 28\/400 de 60 ml \u00e0 ouverture par pression est le format de r\u00e9f\u00e9rence des flacons CRC IBM utilis\u00e9s dans l'industrie pharmaceutique cor\u00e9enne\u00a0; il s'agit du flacon CRC de plus grand volume pour les prescriptions d'antibiotiques p\u00e9diatriques en Cor\u00e9e. Les fabricants cor\u00e9ens d'IBM qualifient g\u00e9n\u00e9ralement ce format en premier et l'utilisent comme format de r\u00e9f\u00e9rence pour la planification de la production de flacons CRC multiformats.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S7 \u2550\u2550 --><\/p>\n<section id=\"s7\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 07<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">Format combin\u00e9 CRC + Scellage par induction<\/h2>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Le format combin\u00e9 CRC + scellage par induction \u2014 un surbouchon CRC appliqu\u00e9 sur un contenant scell\u00e9 par induction \u2014 repr\u00e9sente l'exigence de pr\u00e9cision la plus stricte impos\u00e9e par IBM pour le goulot des flacons pharmaceutiques cor\u00e9ens. La r\u00e9glementation cor\u00e9enne HIRA relative aux m\u00e9dicaments liquides p\u00e9diatriques sur ordonnance impose de plus en plus souvent la pr\u00e9sence simultan\u00e9e d'un CRC (s\u00e9curit\u00e9 enfant) et d'un scellage par induction (inviolabilit\u00e9, barri\u00e8re contre l'humidit\u00e9) sur le m\u00eame flacon primaire. Cette sp\u00e9cification combin\u00e9e exige d'IBM la production simultan\u00e9e de trois dispositifs de pr\u00e9cision ind\u00e9pendants sur un seul insert de goulot.<\/p>\n<p><!-- three requirements panel --><\/p>\n<div style=\"display: flex; flex-direction: column; gap: 0; border: 1px solid #1e3a5f; border-radius: 6px; overflow: hidden; margin: 0 0 22px;\">\n<div style=\"background: #0f1e35; display: grid; grid-template-columns: repeat(3,1fr); gap: 0;\">\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">DEMANDE 01<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">Diam\u00e8tre ext\u00e9rieur du bille CRC<\/span><\/p>\n<\/div>\n<div style=\"padding: 12px 18px; border-right: 1px solid #1e3a5f; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">REQ 02<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">Scellement des terrains plats<\/span><\/p>\n<\/div>\n<div style=\"padding: 12px 18px; display: flex; align-items: center; gap: 8px;\">\n<div style=\"background: #d97706; color: #fff; font-size: 9px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">DEMANDE 03<\/div>\n<p><span style=\"font-size: 11px; font-weight: bold; color: #f59e0b; letter-spacing: 0.5px; text-transform: uppercase;\">Diam\u00e8tre ext\u00e9rieur du filetage<\/span><\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fff; display: grid; grid-template-columns: repeat(3,1fr); gap: 0; border-top: 1px solid #e2e8f0;\">\n<div style=\"padding: 16px 18px; border-right: 1px solid #e2e8f0; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">Fonction de pouss\u00e9e et de rotation CRC \u2014 interf\u00e9rence d'engagement du cliquet dans la plage de la norme cor\u00e9enne ISO 8317<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; border-right: 1px solid #e2e8f0; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,10 mm TIR<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">Liaison herm\u00e9tique par feuille d'induction \u2014 contact p\u00e9rim\u00e9trique complet entre la feuille et la surface d'\u00e9tanch\u00e9it\u00e9 en PEHD dans les 14 cavit\u00e9s<\/p>\n<\/div>\n<div style=\"padding: 16px 18px; text-align: center;\">\n<p style=\"font-size: 22px; font-weight: 900; color: #d97706; margin: 0 0 4px;\">\u00b10,05 mm<\/p>\n<p style=\"font-size: 13px; color: #374151; margin: 0; line-height: 1.6;\">CRC thread engagement \u2014 Korean pharmacist&#8217;s twist-off overcap engagement after induction seal broken<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #fffbeb; padding: 12px 20px; border-top: 1px solid #fde68a; display: flex; align-items: center; gap: 10px;\">\n<div style=\"width: 6px; height: 6px; background: #d97706; border-radius: 50%; flex-shrink: 0;\"><\/div>\n<p style=\"font-size: 13px; color: #92400e; margin: 0; font-weight: 600; line-height: 1.5;\">All three requirements are met simultaneously by IBM&#8217;s injection mould neck insert \u2014 produced in a single S136 stainless steel insert machined to \u00b10.01 mm on all three geometry features. No secondary processing required. EBM cannot achieve any of the three requirements without secondary neck finishing.<\/p>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The combined CRC + induction seal IBM container qualification for Korean KFDA requires two separate closure function tests included in the container technical file: the Korean KS M ISO 8317 CRC effectiveness test (human panel, 200 adults + 200 children) and the induction seal integrity test (100% bubble test at 10 kPa, plus peel force \u2265 8 N\/15 mm width). Both tests must use production containers from the same IBM production run at the qualified machine and cavity count. Korea Ever-Power&#8217;s pre-delivery production trial produces sample containers for both test submissions simultaneously, providing the Korean pharmaceutical brand with all required test samples within a single pre-delivery production batch.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 S8 \u2550\u2550 --><\/p>\n<section id=\"s8\" style=\"margin: 56px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 22px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #fff; border: 1px solid #e2e8f0; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">SECTION 08<\/p>\n<h2 style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #0f1e35; margin: 0; line-height: 1.2;\">S\u00e9lection de la s\u00e9rie ZQ pour la production IBM CRC cor\u00e9enne<\/h2>\n<\/div>\n<\/div>\n<figure style=\"margin: 0 0 24px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 3px; display: block; border: 1px solid #cbd5e0;\" title=\"Korea Ever-Power Workshop \u2014 CRC Pharmaceutical IBM Manufacturing\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/07\/ever-power-workshop-1.webp\" alt=\"Korea Ever-Power IBM machine manufacturing workshop \u2014 ZQ series CRC pharmaceutical IBM machine pre-delivery production trial with engagement bead dimensional report generation for Korean KFDA pharmaceutical container technical file KS M ISO 8317 CRC qualification\" \/><figcaption style=\"font-size: 12px; color: #64748b; margin-top: 8px; padding-left: 10px; border-left: 2px solid #d97706;\">Site de production Korea Ever-Power \u2014 Essai de production IBM de conteneurs pharmaceutiques CRC avant livraison. Le diam\u00e8tre ext\u00e9rieur de la bille d'engagement de chaque conteneur CRC produit lors de cet essai est mesur\u00e9 \u00e0 4 positions angulaires (0\u00b0, 90\u00b0, 180\u00b0, 270\u00b0) afin de confirmer une circularit\u00e9 \u2264 0,04 mm TIR. Cette exigence de circularit\u00e9 garantit un engagement constant du cliquet CRC \u00e0 toutes les positions de rotation lors du test de panneau cor\u00e9en KS M ISO 8317.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">ZQ series machine selection for Korean CRC pharmaceutical IBM follows the same annual volume framework as other pharmaceutical IBM formats. The CRC-specific consideration is that CRC containers at the same volume typically allow fewer cavities per ZQ model versus non-CRC containers of the same volume \u2014 because the CRC engagement bead&#8217;s larger neck OD (bead OD is typically 1.6\u20133.0 mm larger than the nominal neck OD) increases the per-cavity injection clamping requirement and the platen footprint per cavity.<\/p>\n<div style=\"background: #0f1e35; border-radius: 4px; overflow: hidden; border-top: 3px solid #d97706; margin: 0 0 22px;\">\n<div style=\"padding: 14px 20px; border-bottom: 1px solid #1e3a5f;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0;\">MATRICE DE S\u00c9LECTION ZQ \u00b7 CRC IBM @ 60 ml 28\/400 POUSSER ET TOURNER (HDPE MI 0,6)<\/p>\n<\/div>\n<div style=\"overflow-x: auto;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 580px;\">\n<thead>\n<tr style=\"background: #1e3a5f;\">\n<th style=\"color: #f59e0b; padding: 10px 12px; text-align: left; font-weight: bold; border-right: 1px solid #0f1e35;\">MOD\u00c8LE ZQ<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">CAV \u00e0 60 ml CRC<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">BOUTEILLES\/HEURE<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: center; font-weight: bold; border-right: 1px solid #0f1e35;\">PLAFOND ANNUEL<\/th>\n<th style=\"color: #e2e8f0; padding: 10px 10px; text-align: left; font-weight: bold;\">PROFIL DE CRC PHARMA COR\u00c9EN<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #0f1e35;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #94a3b8;\">EP-ZQ40<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">6\u20138<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">~4 800\u20136 400<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #94a3b8;\">~16,8\u201322,4 M<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">Start-up pharmaceutique cor\u00e9enne, essai clinique cor\u00e9en sur le cancer colorectal, maladie p\u00e9diatrique rare en Cor\u00e9e<\/td>\n<\/tr>\n<tr style=\"background: #122338;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #e2e8f0;\">EP-ZQ60<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">10\u201312<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~8 000\u20139 600<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~28,0\u201333,6M<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">M\u00e9dicaments g\u00e9n\u00e9riques cor\u00e9ens contre le cancer colorectal p\u00e9diatrique de taille moyenne<\/td>\n<\/tr>\n<tr style=\"background: #fff9ec; border: 1px solid #d97706;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; font-weight: bold; color: #d97706;\">EP-ZQ80 \u2605<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">14<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">~11,200<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; border-right: 1px solid #fde68a; text-align: center; font-weight: bold; color: #0f1e35;\">~39,2 millions<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #fde68a; font-size: 12px; font-weight: 600; color: #92400e;\">Antibiotique p\u00e9diatrique de marque nationale cor\u00e9enne CRC OEM \u2014 plateforme de r\u00e9f\u00e9rence<\/td>\n<\/tr>\n<tr style=\"background: #122338;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; font-weight: bold; color: #e2e8f0;\">EP-ZQ110<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">18<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~14,400<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; border-right: 1px solid #1e3a5f; text-align: center; color: #e2e8f0;\">~50,4 millions<\/td>\n<td style=\"padding: 9px 10px; border-bottom: 1px solid #1e3a5f; font-size: 12px; color: #64748b;\">grand fabricant cor\u00e9en de produits pharmaceutiques sous contrat, marque p\u00e9diatrique majeure cor\u00e9enne<\/td>\n<\/tr>\n<tr style=\"background: #0f1e35;\">\n<td style=\"padding: 9px 12px; border-right: 1px solid #1e3a5f; font-weight: bold; color: #f59e0b;\">EP-ZQ135<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">22<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">~17,600<\/td>\n<td style=\"padding: 9px 10px; border-right: 1px solid #1e3a5f; text-align: center; font-weight: bold; color: #f59e0b;\">~61,6 millions<\/td>\n<td style=\"padding: 9px 10px; font-size: 12px; color: #64748b;\">Cha\u00eene d'approvisionnement nationale cor\u00e9enne en antibiotiques p\u00e9diatriques, approvisionnement des h\u00f4pitaux cor\u00e9ens en CRC \u00e0 grande \u00e9chelle<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Le <a style=\"color: #1e3a5f; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/product\/ep-zq80-injection-blow-molding-machine-european-style\/\">EP-ZQ80<\/a> at 14-cavity 60 ml CRC is the Korean pharmaceutical CRC IBM benchmark \u2014 covering 39M annual CRC paediatric syrup units per Korean 2-shift year within a single machine qualified for Korean KFDA pharmaceutical GMP. The ZQ80 dual hydraulic system (standard, 20\u201330% energy saving) reduces HVAC load in Korean pharmaceutical cleanroom CRC production, and the machine&#8217;s angle divider mechanism ensures that bead OD cavity-to-cavity standard deviation (\u00b11.8% CV% at 14 cavities on ZQ80) stays well below the \u00b10.05 mm specification at the 99.7th percentile of the production distribution \u2014 confirmed in Korea Ever-Power&#8217;s pre-delivery bead OD circularity and cavity-to-cavity dimensional reports provided with every pharmaceutical CRC IBM machine delivery.<\/p>\n<\/section>\n<p><!-- \u2550\u2550 FAQ \u2550\u2550 --><\/p>\n<section style=\"margin: 64px 0 0;\">\n<div style=\"display: flex; align-items: stretch; gap: 0; margin-bottom: 24px;\">\n<div style=\"width: 4px; background: linear-gradient(180deg,#d97706,#f59e0b); border-radius: 2px; flex-shrink: 0;\"><\/div>\n<div style=\"padding: 10px 16px; background: #0f1e35; border-left: none; flex: 1;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 3px;\">FAQ ING\u00c9NIERIE<\/p>\n<h2 id=\"faq\" style=\"font-size: clamp(17px,2.4vw,22px); font-weight: 800; color: #fff; margin: 0; line-height: 1.2;\">CRC Pharmaceutical IBM \u2014 Questions d'ing\u00e9nierie<\/h2>\n<\/div>\n<\/div>\n<div style=\"display: flex; flex-direction: column; gap: 2px;\">\n<div style=\"border: 1px solid #e2e8f0; border-radius: 4px 4px 0 0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 01<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Pourquoi IBM est-il le seul proc\u00e9d\u00e9 de moulage par soufflage viable pour les contenants CRC pharmaceutiques cor\u00e9ens\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">IBM is the only viable blow molding process for Korean pharmaceutical CRC containers because the Korean KS M ISO 8317 CRC engagement bead OD tolerance requirement (\u00b10.06 mm) falls within IBM&#8217;s native process capability (\u00b10.05 mm) but exceeds EBM&#8217;s achievable tolerance (\u00b10.15\u20130.25 mm) by 2.5\u20134\u00d7 at best. This is not a marginal difference that secondary neck processing can bridge: EBM neck reaming operations have their own dimensional variation (typically \u00b10.08\u20130.12 mm reaming tolerance) that equals or exceeds the entire \u00b10.06 mm ISO 8317 engagement window. Even if individual EBM containers are reamed to within \u00b10.06 mm of bead OD nominal, the reaming operation&#8217;s inter-cycle variation causes some fraction of the production lot to be outside the window at each end of the tolerance \u2014 and Korean KS M ISO 8317 human panel tests all 200 adult and 200 child subjects with the same container type, so any systematic OD variation across the production lot (which EBM + reaming produces) will generate a proportion of containers that either fail child resistance (too wide) or fail adult accessibility (too narrow). IBM eliminates this problem structurally: the IBM injection mould neck insert produces all cavities at nominal \u00b10.05 mm with no secondary processing, no inter-cycle reaming variation, and no process chain in which a secondary operation can introduce dimensional outliers. This structural advantage is why Korean pharmaceutical regulatory bodies accept IBM CRC containers on the basis of IBM machine and mould qualification dimensional documentation alone, without requiring secondary processing verification \u2014 a simplification that EBM + reaming cannot achieve.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 02<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Qu\u2019est-ce qui provoque l\u2019\u00e9chec des tests d\u2019accessibilit\u00e9 pour adultes d\u2019un conteneur IBM pharmaceutique CRC cor\u00e9en\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Korean CRC pharmaceutical IBM container adult accessibility failures \u2014 where more than 15% of the 200 adult test subjects (aged 50\u201370) cannot open the container within 5 minutes \u2014 trace to three causes from the IBM container side. First, bead OD above specification upper limit: a bead OD higher than nominal + 0.05 mm increases the CRC cap&#8217;s push-down engagement force beyond the elderly Korean adult&#8217;s hand grip and push-down capability \u2014 the container is effectively too child-resistant to pass adult accessibility. Diagnostic: measure bead OD from all cavities with bead OD near or above the specification upper limit. Root cause: injection mould neck insert bead OD above nominal (requires insert re-measurement and possible re-machining); or HDPE shrinkage below expected (occurs when mould temperature is lower than qualified baseline, producing less crystallisation and therefore less shrinkage, and a larger bead OD than shrinkage compensation predicted \u2014 increase mould neck zone cooling to intended setpoint). Second, bead profile radius too sharp: an angular bead profile (radius &lt; 0.3 mm) produces a step function in the CRC cap engagement force \u2014 the force required spikes sharply as the cap ratchet engages the bead, rather than building gradually, making the engagement feel sudden and resistant. IBM bead profile radius should be R 0.3\u20130.6 mm as specified in Section 4. Third, HDPE creep enlargement of effective bead OD: if the HDPE IBM container has been stored at elevated temperature before ISO 8317 testing (above 30\u00b0C for extended periods), the bead can creep outward under the sustained engagement force from a previously applied CRC cap, effectively widening the bead OD above nominal. Korean pharmaceutical brands should specify that IBM containers used for ISO 8317 testing have not been subjected to temperatures above 25\u00b0C after production, and should conduct ISO 8317 testing within 90 days of IBM production to avoid thermally induced bead OD drift in the test sample population.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 03<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Does the CRC engagement bead OD need to be specified separately from the Korean CRC cap supplier&#8217;s drawing, or does the IBM mould follow the cap supplier&#8217;s nominal?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">The IBM container engagement bead OD must be specified separately from the Korean CRC cap supplier&#8217;s engagement drawing nominal \u2014 it cannot simply follow the cap nominal without accounting for the engagement system&#8217;s designed interference fit. The push-and-turn CRC mechanism functions by the CRC cap&#8217;s retention ratchet engaging the bottle neck bead with a designed interference: the cap&#8217;s ratchet engagement diameter is intentionally smaller than the bead OD nominal by the designed interference amount (typically 0.10\u20130.20 mm, specified by the Korean CRC cap manufacturer). If the IBM container bead OD equals the CRC cap&#8217;s engagement ratchet nominal \u2014 without the designed interference \u2014 the ratchet slides over the bead without snapping engagement, producing a container that passes adult accessibility (easily opened) but fails child resistance (children can also open it trivially). The correct IBM bead OD specification is: Korean CRC cap supplier&#8217;s engagement ratchet nominal + designed interference (from the CRC cap supplier&#8217;s mating component drawing) = IBM container bead OD nominal, with \u00b10.05 mm IBM tolerance applied. Korea Ever-Power requires the Korean pharmaceutical brand to provide the Korean CRC cap supplier&#8217;s engagement drawing before IBM neck insert CNC machining \u2014 the bead OD nominal dimension machined into the neck insert is derived from the CRC cap drawing, not from a generic pharmaceutical IBM standard. Without this cap supplier drawing, the IBM mould neck insert cannot be correctly dimensioned, and ISO 8317 testing failure is likely on the first submission.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 04<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">La m\u00eame machine ZQ peut-elle ex\u00e9cuter \u00e0 la fois les formats pharmaceutiques IBM CRC et non-CRC\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Yes \u2014 the same ZQ series machine can run CRC and non-CRC pharmaceutical IBM formats using different mould sets, with each mould set&#8217;s production recipe stored in the ZQ control system and recalled by the operator during mould change. A ZQ80 that runs a 14-cavity 60 ml CRC paediatric syrup mould set (HDPE MI 0.6, hold pressure 70%, neck cooling 13\u00b0C) can also run a 20-cavity 10 ml ophthalmic mould set (HDPE MI 0.4, hold pressure 60%, neck cooling 15\u00b0C) after a mould change and recipe recall \u2014 the machine hardware does not change between formats. The Korean KFDA pharmaceutical container qualification, however, is container-specific: the 60 ml CRC mould set and the 10 ml ophthalmic mould set each require their own separate container technical files with their own cavity-by-cavity dimensional reports \u2014 both produced at the same ZQ80 machine serial number but from different mould sets. Korean pharmaceutical IBM producers should identify both mould sets in the machine&#8217;s qualification documentation \u2014 recording both mould serial numbers against the single ZQ80 machine serial number in their Korean GMP production master file \u2014 to support the audit trail for Korean MFDS GMP inspections of multi-format pharmaceutical IBM production on the same machine.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; overflow: hidden; margin-bottom: 2px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 05<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">Comment le diam\u00e8tre ext\u00e9rieur de la bille d'engagement IBM est-il v\u00e9rifi\u00e9 apr\u00e8s la livraison du moule Korea Ever-Power et avant la soumission de la qualification KFDA cor\u00e9enne\u00a0?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">IBM engagement bead OD verification for Korean KFDA CRC qualification uses a specific measurement protocol that differs from standard pharmaceutical neck OD measurement. Standard pharmaceutical neck OD measurement uses a contact digital caliper or laser OD gauge measuring the neck&#8217;s largest diameter in a single plane. CRC engagement bead OD measurement requires: (1) Measurement at 4 angular positions around the bead circumference (0\u00b0, 90\u00b0, 180\u00b0, 270\u00b0) per container \u2014 confirming bead circularity (out-of-roundness \u2264 0.04 mm TIR) as well as bead OD nominal; (2) Measurement at the maximum bead diameter point (the bead&#8217;s highest point above the neck cylinder) \u2014 using a step-gauge contact probe rather than a caliper, because caliper jaws that span the full neck diameter measure the neck OD average rather than the bead OD maximum; (3) Statistical analysis: 30 measurements per cavity (120 measurement readings per cavity for the 4-angular-position protocol) across all production cavities, with Cpk \u2265 1.33 confirmation for bead OD at the specification of nominal \u00b10.05 mm. Korea Ever-Power uses a dedicated bead OD step-gauge contact measurement system during the pre-delivery production trial, with data output directly to the cavity-by-cavity bead OD dimensional report format required for Korean pharmaceutical container technical file submission. This dedicated measurement system is not available at most Korean IBM container producer facilities \u2014 Korea Ever-Power provides the pre-delivery bead OD report precisely because this specialised measurement data is typically not reproducible at the Korean customer&#8217;s production facility without Korea Ever-Power&#8217;s measurement tooling support.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #e2e8f0; border-radius: 0 0 4px 4px; overflow: hidden; margin-bottom: 64px;\">\n<div style=\"background: #1e3a5f; padding: 13px 18px; display: flex; align-items: center; gap: 10px;\"><span style=\"background: #d97706; color: #fff; font-size: 10px; font-weight: 800; padding: 2px 8px; border-radius: 2px; flex-shrink: 0;\">Q 06<\/span><\/p>\n<p style=\"font-size: 14px; font-weight: bold; color: #fff; margin: 0; line-height: 1.3;\">What happens to Korean CRC pharmaceutical IBM container child resistance over the product&#8217;s 24-month shelf life?<\/p>\n<\/div>\n<div style=\"padding: 18px 20px; background: #fff;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.75;\">Korean CRC pharmaceutical IBM container child resistance changes over the 24-month Korean shelf life through two mechanisms: HDPE engagement bead OD drift and CRC cap spring ratchet fatigue. IBM container-side bead OD drift: HDPE crystallisation continues slowly at ambient Korean storage temperatures (15\u201325\u00b0C retail pharmacy storage, 10\u201330\u00b0C Korean household storage) for approximately 6\u201312 months after production \u2014 during this period, the bead OD typically decreases slightly (0.01\u20130.03 mm) due to continuing crystalline-phase densification. This OD decrease slightly increases the CRC engagement interference, making the container marginally more child-resistant at 6\u201312 months versus at production \u2014 a generally conservative change for Korean KFDA compliance purposes. After 12 months, HDPE crystallisation is complete and bead OD is dimensionally stable for the remainder of the 24-month shelf life under normal Korean pharmaceutical storage conditions. CRC cap spring ratchet fatigue (a cap-side issue rather than IBM container-side): the CRC cap&#8217;s polypropylene spring ratchet teeth lose approximately 8\u201315% of their elastic modulus over 24 months at 20\u201325\u00b0C Korean storage \u2014 slightly reducing the push-down force required to depress the ratchet over the bead and potentially increasing the proportion of Korean adult test subjects who could open the container in the ISO 8317 re-test at 24 months. Korean pharmaceutical brands who specify CRC containers for 24-month Korean shelf life should verify with their Korean CRC cap supplier that the cap&#8217;s spring ratchet fatigue data (elastic modulus retention at 24 months at Korean storage conditions) supports continued ISO 8317 adult accessibility and child resistance compliance through shelf life \u2014 the IBM container&#8217;s bead OD stability is not the limiting factor; the cap&#8217;s material performance is.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- CTA --><\/p>\n<div style=\"margin: 0 0 72px; background: #0f1e35; border-radius: 4px; overflow: hidden; position: relative;\">\n<div style=\"height: 4px; background: linear-gradient(90deg,#d97706,#f59e0b,#d97706);\"><\/div>\n<div style=\"position: absolute; right: 0; top: 0; bottom: 0; width: 40%; background: linear-gradient(135deg,transparent 0%,rgba(30,58,95,0.5) 100%); pointer-events: none;\"><\/div>\n<div style=\"position: relative; padding: clamp(32px,5vw,52px) clamp(24px,4vw,48px); text-align: center;\">\n<p style=\"font-size: 9px; font-weight: 800; letter-spacing: 3px; text-transform: uppercase; color: #d97706; margin: 0 0 14px;\">DEMANDE D'INFORMATION CRC PHARMACEUTICAL IBM \u00b7 COR\u00c9E EVER-POWER<\/p>\n<h2 style=\"font-size: clamp(18px,3vw,28px); font-weight: 900; color: #fff; margin: 0 0 14px; letter-spacing: -0.5px;\">Planification de la production de conteneurs IBM pour le secteur pharmaceutique cor\u00e9en CRC\u00a0?<\/h2>\n<p style=\"font-size: 15px; color: #94a3b8; max-width: 520px; margin: 0 auto 28px; line-height: 1.65;\">Korea Ever-Power fournit la qualification dimensionnelle du diam\u00e8tre ext\u00e9rieur des billes d'engagement CRC \u00e0 partir de l'essai de production avant livraison, les conteneurs d'\u00e9chantillons de test cor\u00e9ens KS M ISO 8317, le dossier de documentation KFDA GMP et la s\u00e9lection de machines de la s\u00e9rie ZQ pour la production de conteneurs pharmaceutiques CRC cor\u00e9ens IBM \u00e0 tous les volumes de production annuels.<\/p>\n<p><a style=\"display: inline-flex; align-items: center; gap: 8px; background: #d97706; color: #fff; padding: 14px 36px; border-radius: 3px; text-decoration: none; font-weight: 800; font-size: 14px; letter-spacing: 0.5px; text-transform: uppercase;\" href=\"https:\/\/isbm-blow-molding.com\/fr\/contact-us\/\">Demande de consultation CRC IBM <span style=\"font-size: 16px;\">\u2192<\/span><\/a><\/p>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>CRC PHARMACEUTICAL IBM \u00b7 KS M ISO 8317 \u00b7 KOREAN KFDA \u00b7 KOREA EVER-POWER CRC Pharmaceutical IBM: Child-Resistant Container Guide Korean child-resistant closure (CRC) pharmaceutical containers are the application where IBM&#8217;s \u00b10.05 mm neck OD precision is not merely an advantage over EBM \u2014 it is the prerequisite for Korean KS M ISO 8317 compliance. [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-1084","post","type-post","status-publish","format-standard","hentry","category-technical-deep-dive"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/comments?post=1084"}],"version-history":[{"count":2,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1084\/revisions"}],"predecessor-version":[{"id":1088,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/posts\/1084\/revisions\/1088"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/media?parent=1084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/categories?post=1084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/fr\/wp-json\/wp\/v2\/tags?post=1084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}